Xeris Pharmaceuticals Inc. (XERS) Reports In-Line Q2 EPS ; Offers Guidance

Go back to Xeris Pharmaceuticals Inc. (XERS) Reports In-Line Q2 EPS ; Offers Guidance
(NASDAQ: XERS) Delayed: 8.59 +0.26 (3.12%)
Previous Close $8.33    52 Week High
Open $8.33    52 Week Low
Day High $8.62    P/E N/A 
Day Low $8.25    EPS
Volume 430,843